Association between Antiviral Prophylaxis and Cytomegalovirus and Epstein-Barr Virus DNAemia in Pediatric Recipients of Allogeneic Hematopoietic Stem Cell Transplant.
Ndeye Soukeyna DiopPascal Roland Enok BonongChantal ButeauMichel DuvalJacques LacroixLouise LaporteMarisa TucciNancy RobitaillePhilip C SpinellaGeoffrey CuvelierSuzanne M VercauterenVictor LewisCaroline AlfieriHelen TrottierPublished in: Vaccines (2021)
The antivirals famciclovir and acyclovir did not reduce the risk of post-transplant CMV and EBV DNAemia among HSCT recipients in our pediatric population.